secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001213900-23-001717
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Preliminary FY2022 revenue exceeds $44M (60% growth); profitable Q4 and FY; COO appointed
--------------------------------------------------------------------------------

- Preliminary Q4 2022 revenues expected to exceed $13M; full-year 2022 revenues exceed $44M (60% growth over 2021).
- Sensus expects both Q4 and full-year 2022 to be profitable; Q4 aesthetics revenue over $500K.
- Magdalena Martinez named COO, replacing Nicolas Soro, effective January 3, 2023. She previously served as VP of Operations.
- Company plans to expand sales force, increase trade show presence, and submit new technologies to FDA in H2 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000121390023001717/0001213900-23-001717-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000121390023001717/ea171415-8k_sensus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-001717

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer